News
Public · Published
Bata India shares fall after Citi cuts target post weak Q2, warns of further valuation de-rating
Bata India shares traded around 4% lower on November 4 after its September-quarter revenue rose 7.6% year on year to ₹862 crore, while EBITDA fell 0.7% to ₹144 crore and its EBITDA margin narrowed to 16.7%. Citi kept its Sell recommendation and cut its price target to ₹550 from ₹675.
Published:
Updated:
What happened
Bata India shares traded around 4% lower on November 4 after its September-quarter revenue rose 7.6% year on year to ₹862 crore, while EBITDA fell 0.7% to ₹144 crore and its EBITDA margin narrowed to 16.7%. Citi kept its Sell recommendation and cut its price target to ₹550 from ₹675.
Confirmed
Global impact / market context
Revenue growth did not translate into stronger operating results: EBITDA, a measure of earnings before interest, taxes, depreciation and amortization, edged down, and the profit earned on each rupee of revenue narrowed. If that weakness persists, it could limit cash available for investment and make earnings growth harder to sustain.
Analyst inference
Citi’s lower target and continued Sell recommendation reflect concern that modest sales growth and weaker operating profitability could weigh on how investors value Bata India. The company said festive-season business shifting to the December quarter is expected to support growth, so upcoming results will show whether that timing effect helps.
Analyst inference
What to watch
- Check the December-quarter results for evidence that festive-related business shifted from September into the later quarter, as the company said it expected growth momentum to improve. Confirmed
- Watch whether revenue growth strengthens while EBITDA and its share of revenue recover; continued weakness could constrain funds available for operations and investment. Analyst inference
- Compare subsequent company results with Citi’s ₹550 target and Sell recommendation to see whether the brokerage changes its view as new performance data arrives. Analyst inference
Evidence
- Original source link unavailable